Philanthropy and community engagement have become integral parts of business, but there are many ways and means by which companies can organize and manage such efforts. For some companies, foundations offer a convenient mechanism to oversee social investments, while others may choose to give solely from within a corporate giving platform. We know that society’s expectations of firms are high and there are therefore many reasons a company may decide to give, including:
#BlackFriday. #CyberMonday. #GivingTuesday.
It’s been a week since this new tradition of generosity took place on December 2, 2014, and the data is in: the giving economy is thriving.
Founded in 2012 by the 92nd Street Y and the United Nations Foundation, #GivingTuesday provides a global stage to promote, celebrate and encourage the act of giving at the beginning of the holiday season.
The face of corporate philanthropy is changing. No longer are companies simply writing checks from their corporate foundations, taking a traditional grant-maker role and leaving the work to charities. Increasingly, we want to roll up our sleeves — still providing essential funding, but also manpower, services and expertise. And, we want measurable impacts.
Last year, my team met a little girl named Brooke Hester, who reminded me why this shift is so vitally important.
Brooke is a bubbly 5-year-old from Kingsville, Texas, who loves to dance and play. She is also part of an FDA-approved personalized medicine clinical trial for children with a cancer called neuroblastoma, run by the Neuroblastoma and Medulloblastoma Translational Research Consortium. Doctors and researchers in this trial are using Dell-donated technology to analyze massive amounts of genetic data from a child’s tumor to identify the round of drugs and precise doses most likely to have a positive impact.